AnGriMax

AnGriMax is a multi-component small molecule pharmaceutical product developed and manufactured by the Belarusian company Minskintercaps. It is specifically formulated for the short-term treatment of influenza (particularly Influenza A), common colds, and associated respiratory conditions such as rhinitis and rhinopharyngitis. The medication combines several active ingredients to address a broad spectrum of symptoms: rimantadine provides targeted antiviral activity by inhibiting the M2 ion channel of the Influenza A virus; paracetamol acts as an analgesic and antipyretic by inhibiting cyclooxygenase enzymes; and loratadine serves as a non-sedating H1-histamine receptor antagonist to alleviate allergic-like symptoms such as sneezing and nasal discharge. Additionally, the formulation includes ascorbic acid (Vitamin C) for immune support, along with rutoside and calcium gluconate to stabilize capillary walls and reduce vascular permeability. It is typically administered orally in capsule form for adults and adolescents aged 12 and older.

Brand names

AnGriMaxАнГриМакс